Effectiveness and safety of electronically delivered prescribing feedback and decision support on antibiotic use for respiratory illness in primary care: REDUCE cluster randomised trial.
OBJECTIVES: To evaluate the effectiveness and safety at population scale of electronically delivered prescribing feedback and decision support interventions at reducing antibiotic prescribing for self limiting respiratory tract infections.
DESIGN: Open label, two arm, cluster randomised controlled trial.
SETTING: UK general practices in the Clinical Practice Research Datalink, randomised between 11 November 2015 and 9 August 2016, with final follow-up on 9 August 2017.
PARTICIPANTS: 79 general practices (582 675 patient years) randomised (1:1) to antimicrobial stewardship (AMS) intervention or usual care.
INTERVENTIONS: AMS intervention comprised a brief training webinar, automated monthly feedback reports of antibiotic prescribing, and electronic decision support tools to inform appropriate prescribing over 12 months. Intervention components were delivered electronically, supported by a local practice champion nominated for the trial.
MAIN OUTCOME MEASURES: Primary outcome was the rate of antibiotic prescriptions for respiratory tract infections from electronic health records. Serious bacterial complications were evaluated for safety. Analysis was by Poisson regression with general practice as a random effect, adjusting for covariates. Prespecified subgroup analyses by age group were reported.
RESULTS: The trial included 41 AMS practices (323 155 patient years) and 38 usual care practices (259 520 patient years). Unadjusted and adjusted rate ratios for antibiotic prescribing were 0.89 (95% confidence interval 0.68 to 1.16) and 0.88 (0.78 to 0.99, P=0.04), respectively, with prescribing rates of 98.7 per 1000 patient years for AMS (31 907 prescriptions) and 107.6 per 1000 patient years for usual care (27 923 prescriptions). Antibiotic prescribing was reduced most in adults aged 15-84 years (adjusted rate ratio 0.84, 95% confidence interval 0.75 to 0.95), with one antibiotic prescription per year avoided for every 62 patients (95% confidence interval 40 to 200). There was no evidence of effect for children younger than 15 years (adjusted rate ratio 0.96, 95% confidence interval 0.82 to 1.12) or people aged 85 years and older (0.97, 0.79 to 1.18); there was also no evidence of an increase in serious bacterial complications (0.92, 0.74 to 1.13).
CONCLUSIONS: Electronically delivered interventions, integrated into practice workflow, result in moderate reductions of antibiotic prescribing for respiratory tract infections in adults, which are likely to be of importance for public health. Antibiotic prescribing to very young or old patients requires further evaluation.
TRIAL REGISTRATION: ISRCTN95232781.
|ジャーナル名||BMJ (Clinical research ed.)|
|投稿者||Gulliford, Martin C; Prevost, A Toby; Charlton, Judith; Juszczyk, Dorota; Soames, Jamie; McDermott, Lisa; Sultana, Kirin; Wright, Mark; Fox, Robin; Hay, Alastair D; Little, Paul; Moore, Michael V; Yardley, Lucy; Ashworth, Mark|
|組織名||School of Population Health and Environmental Sciences, King's College London,;Guy's Campus, King's College London, London, UK email@example.com.;NIHR Biomedical Research Centre at Guy's and St Thomas' Hospitals London, London,;UK.;Guy's Campus, King's College London, London, UK.;School of Public Health, Imperial College London, London, UK.;Clinical Practice Research Datalink, Medicines and Healthcare Products Regulatory;Agency, London, UK.;The Health Centre, Bicester, Oxfordshire, UK.;Centre for Academic Primary Care, Bristol Medical School, Population Health;Sciences, University of Bristol, Bristol, UK.;Primary Care Research Group, University of Southampton, Southampton, UK.;Department of Psychology, University of Southampton, Southampton, UK.;School of Psychological Science, University of Bristol, Bristol, UK.|